Atlas Trials

A Follow-up Study of Immune Dysregulation in Patients With COVID-19

Clinical trial NCT05669248 · UNKNOWN

Trial details

NCT number
NCT05669248
Sponsor
Qilu Hospital of Shandong University
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19Immunosuppression
Start date
2023-01-03
Primary completion
2023-09-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.